Nasus Pharma Ltd. engages in the development of intranasal drugs for emergency medical conditions. It offers Powder-Based Intranasal (PBI) specialized product portfolio, to address acute medical conditions and public health threats. The company was founded by Udi Gilboa and Dalia Megiddo in May 2019 and is headquartered in Tel Aviv, Israel.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
7
Frequently Asked Questions
What is Market Cap of Nasus Pharma Ltd.?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Nasus Pharma Ltd. market cap is $25.06M.
What is the 52-week high for Nasus Pharma Ltd.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Nasus Pharma Ltd. 52 week high is $9.99 as of April 29, 2026.
What is the 52-week low for Nasus Pharma Ltd.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Nasus Pharma Ltd. 52 week low is $1.98 as of April 29, 2026.
What is Nasus Pharma Ltd. stock price today?
Nasus Pharma Ltd. stock price today is $2.91.
What was Nasus Pharma Ltd. stock price yesterday?
Nasus Pharma Ltd. stock price yesterday was $3.18.
What is the PE ratio of Nasus Pharma Ltd.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Nasus Pharma Ltd.'s P/E ratio is -15.08.
What is the Price-to-Book ratio of Nasus Pharma Ltd.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Nasus Pharma Ltd. P/B ratio is 30.2055.
What is the 50-day moving average of Nasus Pharma Ltd.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Nasus Pharma Ltd. 50-day moving average is $3.51.